Previous 10 | Next 10 |
Nemaura (NASDAQ: NMRD) , a medical technology company focused on non-invasive wearable sensors and personalized weight reduction programs, today announced the next commercialization stage of its proBEAT(TM) sensor and AI-based feedback platform, augmenting the BEAT(TM) diabetes program. Intended ...
LOUGHBOROUGH, June 27, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on non-invasive wearable sensors and personalized weight reduction programs, announces the next commercialization s...
Nemaura (NASDAQ: NMRD) , a medical technology company focused on non-invasive wearable sensors and personalized weight reduction programs, today announced that it will be participating at the upcoming Collision Conference. The event, being held at the Enercare Centre in Toronto, Canada, on June 2...
LOUGHBOROUGH, June 22, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on non-invasive wearable sensors and personalized weight reduction programs, announces that it will be participating at the upcoming Collision Con...
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized diabetes management and metabolic health programs. The company today announced that it will exhibit and provide product demonstrations of its...
LOUGHBOROUGH, June 15, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized diabetes management and...
Nemaura Medical (NASDAQ: NMRD) CEO DR. Faz Chowdhury will be participating in a fireside chat hosted by EF Hutton research analyst Constantine Davides. The medical technology company, which is focused on developing and commercializing noninvasive wearable diagnostic devices and supporting person...
LOUGHBOROUGH, March 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifest...
Nemaura Medical (NASDAQ: NMRD) , a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs, has added insulin onto the list of drugs under the DuoPack Commercial License Agre...
LOUGHBOROUGH, March 15, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and ...
News, Short Squeeze, Breakout and More Instantly...
Nemaura Medical Inc. Company Name:
NMRD Stock Symbol:
NASDAQ Market:
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take pla...
Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will imp...
Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel gr...